Table 2.
Outcomes
| No lactate | Lactate <4.0 | High lactate | p Value no vs <4.0 | p Value no vs high | p Value <4.0 vs high | |
|---|---|---|---|---|---|---|
| N=200 | N=200 | N=197 | ||||
| Length of stay | 8 (11) | 13 (14) | 15 (±17) | <0.001 | <0.001 | 0.683 |
| ICU/MCU admission | 9 (4.5) | 30 (15.0 | 79 (40.1) | <0.001 | <0.001 | <0.001 |
| ICU restrictions | 36 (18.0) | 71 (35.5) | 53 (26.9) | <0.001 | <0.001 | <0.001 |
| Length of stay in the ICU/MCU | 3 (2–5) | 6 (3–10) | 3.5 (2–7.5) | 0.114 | 0.349 | 0.220 |
| Readmission <28 days | 29 (15.7) | 20 (12.3) | 18 (16.2) | 0.440 | 1.000 | 0.377 |
| 28-day mortality | 19 (9.5) | 37 (18.5) | 80 (40.6) | 0.007 | <0.001 | <0.001 |
| 1-year mortality | 47 (23.5) | 62 (31.0) | 109 (55.3) | 0.061 | <0.001 | <0.001 |
Data are presented as mean±SD, n (%) or as median (IQR).
The length of stay was given in days.
ICU, intensive care unit; MCU, medium care unit.